ALPRAZOLAM and INSOMNIA

Overview

INSOMNIA is the #14 most commonly reported adverse reaction for ALPRAZOLAM, manufactured by Viatris Specialty LLC. There are 7,177 FDA adverse event reports linking ALPRAZOLAM to INSOMNIA. This represents approximately 1.7% of all 413,410 adverse event reports for this drug.

Patients taking ALPRAZOLAM who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

INSOMNIA is a less commonly reported adverse event for ALPRAZOLAM, but still significant enough to appear in the safety profile.

Other Side Effects of ALPRAZOLAM

In addition to insomnia, the following adverse reactions have been reported for ALPRAZOLAM:

• DRUG INEFFECTIVE — 13,400 reports
• NAUSEA — 12,850 reports
• FATIGUE — 11,934 reports
• DRUG ABUSE — 10,942 reports
• ANXIETY — 10,169 reports
• HEADACHE — 9,922 reports
• PAIN — 9,820 reports
• TOXICITY TO VARIOUS AGENTS — 8,864 reports
• DIARRHOEA — 8,783 reports
• DYSPNOEA — 8,258 reports

Other Drugs Associated with INSOMNIA

The following drugs have also been linked to insomnia in FDA adverse event reports:

Does ALPRAZOLAM cause INSOMNIA?

INSOMNIA has been reported as an adverse event in 7,177 FDA reports for ALPRAZOLAM. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is INSOMNIA with ALPRAZOLAM?

INSOMNIA accounts for approximately 1.7% of all adverse event reports for ALPRAZOLAM, making it a notable side effect.

What should I do if I experience INSOMNIA while taking ALPRAZOLAM?

If you experience insomnia while taking ALPRAZOLAM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages